When a novel coronavirus struck in early 2020, Pfizer ’s PFE 0.24% chief executive, Dr. Albert Bourla, saw an opportunity to help save the world.

Pfizer CEO Albert Bourla expected to meet with activist Starboard next week - FT Oct. 08, 2024 5:26 PM ET Pfizer Inc. (PFE) Stock By: Joshua Fineman, SA News Editor 12 Comments Play (1min) georgeclerk ...

Bourla and at least one other director will hold talks with Starboard next week, after it emerged this weekend the fund had taken a $1bn stake, equivalent to about 0.6 per cent of the $165bn company.

Pfizer’s chief executive, Dr. Albert Bourla, said the drug-making company is in a “very advanced stage” and should know by the end of October whether the coronavirus vaccine they are ...

The Pfizergate scandal broke in 2021, revealing that during the pandemic, European Commission President Ursula von der Leyen had negotiated a contract for 1.8 billion COVID-19 vaccine doses with ...

When Albert Bourla became CEO of Pfizer in 2019, just before the pandemic, he wanted to make Pfizer’s medicines more affordable to more patients. But COVID-19 delayed those plans when Bourla ...

In a difficult year for Pfizer, in which its share price fell by 44%, CEO Albert Bourla’s compensation fell by 35%, from $33M to $21.6M in 2023.

If David Ricks is the best biopharma CEO of 2023, then Pfizer CEO Albert Bourla is, unfortunately, the worst. My annual Worst Biopharma CEO list is typically populated with blockheads and scoundrels.

Pfizer CEO Albert Bourla posted the image on X, formerly Twitter, on Nov. 9. However, Bourla's post clearly states the image was taken "three years ago today," referring to Nov. 9, 2020.

Pfizer chairman and CEO Albert Bourla discusses the path ahead for the company, including its plans for acquisitions. He speaks with Bloomberg Wall Street Week host David Westin. Oct 31, 2023 ...

"Pfizer CEO Albert Burla (sic) is stepping down and now says the mRNA technology was not sufficiently proven when launched," reads the caption of a Dec. 10 Facebook clip (direct link, archived link).

A clip of an old interview showing Pfizer CEO Albert Bourla talking about the U.S. Food and Drug Administration’s approval of the company’s COVID-19 vaccine is circulating on social media.